Literature DB >> 15831958

Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes.

Andrea Hanika1, Birthe Larisch1, Eike Steinmann1, Christel Schwegmann-Weßels1, Georg Herrler1, Gert Zimmer1.   

Abstract

Influenza C virus contains two envelope glycoproteins: CM2, a putative ion channel protein; and HEF, a unique multifunctional protein that performs receptor-binding, receptor-destroying and fusion activities. Here, it is demonstrated that expression of HEF is sufficient to pseudotype replication-incompetent vesicular stomatitis virus (VSV) that lacks the VSV glycoprotein (G) gene. The pseudotyped virus showed characteristic features of influenza C virus with respect to proteolytic activation, receptor usage and cell tropism. Chimeric glycoproteins composed of HEF ectodomain and VSV-G C-terminal domains were efficiently incorporated into VSV particles and showed receptor-binding and receptor-destroying activities but, unlike authentic HEF, did not mediate efficient infection, probably because of impaired fusion activity. HEF-pseudotyped VSV efficiently infected polarized Madin-Darby canine kidney cells via the apical plasma membrane, whereas entry of VSV-G-complemented virus was restricted to the basolateral membrane. These findings suggest that pseudotyping of viral vectors with HEF might be useful for efficient apical gene transfer into polarized epithelial cells and for targeting cells that express 9-O-acetylated sialic acids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831958     DOI: 10.1099/vir.0.80788-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.

Authors:  Markus Hoffmann; Inga Nehlmeier; Constantin Brinkmann; Verena Krähling; Laura Behner; Anna-Sophie Moldenhauer; Nadine Krüger; Julia Nehls; Michael Schindler; Thomas Hoenen; Andrea Maisner; Stephan Becker; Stefan Pöhlmann
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.

Authors:  Étori Aguiar Moreira; Samira Locher; Larissa Kolesnikova; Hardin Bolte; Teresa Aydillo; Adolfo García-Sastre; Martin Schwemmle; Gert Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

4.  Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.

Authors:  Alexander Muik; Inna Kneiske; Marina Werbizki; Doris Wilflingseder; Tsanan Giroglou; Oliver Ebert; Anna Kraft; Ursula Dietrich; Gert Zimmer; Stefan Momma; Dorothee von Laer
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.

Authors:  Mariana González-Hernández; Markus Hoffmann; Constantin Brinkmann; Julia Nehls; Michael Winkler; Michael Schindler; Stefan Pöhlmann
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

6.  Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.

Authors:  Michael A Whitt
Journal:  J Virol Methods       Date:  2010-08-13       Impact factor: 2.014

7.  Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.

Authors:  Heike Hofmann; Xingxing Li; Xiaoai Zhang; Wei Liu; Annika Kühl; Franziska Kaup; Samantha S Soldan; Francisco González-Scarano; Friedemann Weber; Yuxian He; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Rescue of influenza C virus from recombinant DNA.

Authors:  Bernadette Crescenzo-Chaigne; Sylvie van der Werf
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells.

Authors:  Katrin Anne Becker; Alexander Carpinteiro; Markus Hoffmann; Stefan Pöhlmann; Johannes Kornhuber; Erich Gulbins
Journal:  STAR Protoc       Date:  2021-02-03

10.  Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.

Authors:  Stefan J Halbherr; Terza Brostoff; Merve Tippenhauer; Samira Locher; Marianne Berger Rentsch; Gert Zimmer
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.